

Robust Processes From the Start
From bench to commercial scale, we develop bioprocesses built for reproducibility, regulatory confidence, and the long-term success of your program.
Processes Designed for Scale

Upstream Process Development
QbD-aligned fermentation optimization across fed-batch and batch modes, with scale-up bridging from development scale through to GMP production.
01

Downstream Process Development
Full downstream scope covering product recovery, refolding, chromatography, TFF, and hollow-fiber filtration, all designed for commercial scale-up. Inclusion body refolding is supported by a dedicated high-capacity refold platform.
02

Nucleic Acid Process Development
Dedicated pDNA purification laboratory with continuous flow cell lysis, CIM monolith chromatography, and TFF. Dedicated mRNA laboratory covering IVT, downstream purification, and microfluidic encapsulation development using the NanoAssemblr platform.
03

Process Characterization
Critical process parameter identification and design space definition supporting consistent manufacturing performance. Scale-down model development supporting process validation and regulatory submissions.
04

Integrated Analytical Support
Forced degradation studies, in-process testing, and phase-appropriate method development executed in parallel with process development throughout.
05

Scale-Up Ready by Design
Every program begins with a Quality Target Product Profile, establishing a shared understanding of your molecule, critical quality attributes, and the control strategy required to reach scale reliably.
Our analytical team supports upstream, downstream, and formulation screening throughout, so analytical understanding is built into your process from the first experiment.
Manufacturing processes utilize fully enclosed, single-use systems for buffers and process intermediates, maintaining sanitary production conditions throughout development and scale-up.
Processes are developed to mirror production scale directly, with parameters and control strategies aligned from development through GMP manufacture to minimize scale-up risk and rework.
Validation That Stands Up to Inspection

PPQ Campaign Execution
Three-batch Process Performance Qualification (PPQ) campaigns aligned to the FDA validation lifecycle model, generating statistical evidence of process consistency required for commercial product licensure.
01

Cleaning and Sterilization Validation
Validated cleaning procedures confirm residue removal across all manufacturing equipment between campaigns. Sterilization validation covers all applicable methods and formats, including VHP isolator decontamination and Aseptic Process Simulation.
02

Computer System Validation
GMP-critical systems including LIMS, DCS, SCADA, and MES validated under programs aligned with 21 CFR Part 11 and EU Annex 11.
03

Complete Validation Packages
Full documentation supporting BLA, NDA, MAA, and TGA submissions, including Stage 3 Continued Process Verification programs for post-approval statistical process monitoring.
04

A Validated Process,
Built for Commercial Scale
We apply the FDA 2011 Process Validation Guidance three-stage lifecycle model: Stage 1 process design and development, Stage 2 Process Performance Qualification, and Stage 3 Continued Process Verification, aligned to FDA, EMA, and TGA.
CQA and CPP identification and their relationships are defined through process characterization studies during process development, establishing the design space that feeds directly into Stage 2 PPQ protocols.
Validation scope is determined by CQA and CPP criticality, with evidence built progressively from development through commercial manufacturing and documentation aligned to FDA, EMA, and TGA inspection requirements.
BioCina's manufacturing SOPs and quality framework are established under and successfully inspected by the US FDA with zero observations, with the same governing procedures remaining in operation today.
Processes Designed for Scale
Upstream Process Development
QbD-aligned fermentation optimization across fed-batch and batch modes, with scale-up bridging from development scale through to GMP production.
Downstream Process Development
Full downstream scope covering product recovery, refolding, chromatography, TFF, and hollow-fiber filtration, all designed for commercial scale-up. Inclusion body refolding supported by a dedicated DOE-driven platform and a 3,000 L refold tank. Continuous cell lysis scalable to 500 L fermentation.
Nucleic Acid Process Development
Dedicated pDNA purification laboratory with continuous flow cell lysis, CIM monolith chromatography for high supercoiled content and purity, and TFF for concentration and buffer exchange.
Process Characterization
Lorem ipsum

Scale-Up Ready by Design
Quality Target Product Profile First
Every program begins with a Quality Target Product Profile, establishing a shared understanding of your molecule, critical quality attributes, and the control strategy required to reach scale reliably.
Analytical Development in Parallel
Lorem ipsum
Closed, Single-Use Systems
Lorem ipsum
Scale-Up by Design
Lorem ipsum

Discuss Your Program with Us
Connect with our experts and see how science-driven process development accelerates your path from bench to commercial manufacturing.

